Results 1-10 out of 109
-
Interim Management Statement for 3 months ended 30 June 2008
03 July 2008Phytopharm plc (PYM: London Stock Exchange) (“Phytopharm” or the “Company”) is today issuing its Interim Management Statement (“IMS”) which relates to the three month period from 1 April 2008 to 30 June 2008 and contains information up to the date of publication of this IMS.
-
Launch of Phytopica® in Hong Kong
11 June 2008Phytopharm plc (PYM: London Stock Exchange) (“Phytopharm” or the “Company”) announces today the launch of Phytopica® in Hong Kong by its partner, Intervet/Schering-Plough Animal Health.
-
Interim Results
29 May 2008 -
Myogane granted European Union Orphan Medicinal Product Designation for ALS
21 May 2008Phytopharm plc (PYM: London Stock Exchange) (“Phytopharm” or the “Company”) announces today that the European Agency for the Evaluation of Medicinal Products (“EMEA”) has awarded Orphan Medicinal Product Designation for Myogane™, a novel orally active neurotrophic factor inducer as a treatment for amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig’s disease), the most prevalent form of motor neurone disease.
-
Results of Placing and Open Offer
25 March 2008 -
Proposed Placing and Open Offer to raise £8.6 million
28 February 2008 -
Interim Management Statement for 3 months ended 31 December 2007
18 February 2008 -
$1.16 million funding for Cogane™
21 January 2008Phytopharm plc (LSE: PYM) (“Phytopharm” or the “Company”) announces today that it has been awarded funding by The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to support the development of Cogane™ as a treatment for Parkinson’s disease (PD).
-
Preliminary Results for the period ended 30 September 2007
29 November 2007 -
Phytopharm initiates Stage 3 activities of Joint Development Agreement for Hoodia extract with Unilever
24 September 2007GODMANCHESTER, Cambridgeshire, U.K. (24 September 2007) – Phytopharm plc (LSE: PYM) (”Phytopharm”) announces today that it continues to make good progress on its weight management product, Hoodia extract in collaboration with Unilever.